New drug combo aims to tame sleep apnea without CPAP
NCT ID NCT05350215
Summary
This study is testing whether a combination of two drugs, atomoxetine and DAW2020, can reduce the severity of obstructive sleep apnea. Researchers will compare the effects of the drugs to a placebo during overnight sleep studies. The goal is to see if this drug combination can be a new treatment option for people with moderate-to-severe sleep apnea.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBSTRUCTIVE SLEEP APNEA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Brigham and Women's Hospital
RECRUITINGBoston, Massachusetts, 02135, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.